2,866 hedge funds and large institutions have $105B invested in Pfizer in 2024 Q2 according to their latest regulatory filings, with 212 funds opening new positions, 1,179 increasing their positions, 1,238 reducing their positions, and 172 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding in top 10

Funds holding in top 10:

less funds holding

Funds holding:

less capital invested

Capital invested by funds: $ → $

5% less repeat investments, than reductions

Existing positions increased: 1,179 | Existing positions reduced: 1,238

1.16% less ownership

Funds ownership: 67.15%65.99% (-1.2%)

40% less call options, than puts

Call options by funds: $2.36B | Put options by funds: $3.9B

Holders
2,866
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
33
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.36B
Puts
$3.9B
Net Calls
Net Calls Change

Top Buyers

1 +$346M
2 +$334M
3 +$233M
4
Citadel Advisors
Citadel Advisors
Florida
+$217M
5
Norges Bank
Norges Bank
Norway
+$199M
Name Holding Trade Value Shares
Change
Change in
Stake
776
$3.7M
777
$3.69M
778
$3.67M
779
$3.67M
780
$3.65M
781
$3.62M
782
$3.61M
783
$3.61M
784
$3.61M
785
$3.6M
786
$3.6M
787
$3.58M
788
$3.56M
789
$3.56M
790
$3.55M
791
$3.55M
792
$3.55M
793
$3.53M
794
$3.52M
795
$3.52M
796
$3.51M
797
$3.5M
798
$3.48M
799
$3.46M
800
$3.45M